Is oxytocin a maternal-foetal signalling molecule at birth? Implications for development

Journal of Neuroendocrinology

Volumn 26, Issue 10, 2014, Pages 739-749

  Kenkel, W M ^a   Yee, J R ^a   Carter, C S ^a,b  

^a NORTHEASTERN UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Autism spectrum disorder; Brain; Development; Labour; Oxytocin

Indexed keywords

AMINOPEPTIDASE; OXYTOCIN;

AUTISM; BIRTH; BLOOD BRAIN BARRIER; BLOOD PLACENTA BARRIER; FETUS DEVELOPMENT; HUMAN; LABOR INDUCTION; NERVOUS SYSTEM DEVELOPMENT; PREECLAMPSIA; PRIORITY JOURNAL; REVIEW; FEMALE; FETOMATERNAL TRANSFUSION; PHYSIOLOGY; PREGNANCY; SIGNAL TRANSDUCTION;

FEMALE; HUMANS; MATERNAL-FETAL EXCHANGE; OXYTOCIN; PREGNANCY; SIGNAL TRANSDUCTION;

EID: 84927557136     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/jne.12186     Document Type: Review

References (174)

1. Dale HH. On some physiological actions of ergot. J Physiol 1906; 34: 163-206.
2. Pedersen CA, Prange AJ Jr. Induction of maternal behavior in virgin rats after intracerebroventricular administration of oxytocin. Proc Natl Acad Sci USA 1979; 76: 6661-6665.
3. Carter CS, et al. Consequences of early experiences and exposure to oxytocin and vasopressin are sexually dimorphic. Dev Neurosci 2009; 31: 332-341.
4. Mueller-Heubach E, Morris M, Rose JC. Fetal oxytocin and its extended forms at term with and without labor. Am J Obstet Gynecol, 1995; 173: 375-380.
5. Nathanielsz PW. Comparative studies on the initiation of labor. Eur J Obstet Gynecol Reprod Biol 1998; 78: 127-132.
6. Dawood MY, et al. Maternal and fetal plasma oxytocin levels during pregnancy and parturition in the sheep. Am J Obstet Gynecol 1983; 147: 584-588.
7. Dawood MY, et al. Fetal contribution to oxytocin in human labor. Obstet Gynecol 1978; 52: 205-209.
8. de Geest K, et al. Plasma oxytocin in human pregnancy and parturition. J Perinat Med 1985; 13: 3-13.
9. Hirst JJ, et al. Plasma oxytocin and nocturnal uterine activity: maternal but not fetal concentrations increase progressively during late pregnancy and delivery in rhesus monkeys. Am J Obstet Gynecol 1993; 169: 415-422.
10. Gross G, Imamura T, Muglia LJ. Gene knockout mice in the study of parturition. J Soc Gynecol Investig 2000; 7: 88-95.
11. Ratajczak CK, Muglia LJ. Insights into parturition biology from genetically altered mice. Pediatr Res 2008; 64: 581-589.
12. Murata Y, Li MZ, Masuko S. Developmental expression of oxytocin receptors in the neonatal medulla oblongata and pons. Neurosci Lett 2011; 502: 157-161.
13. Tribollet E, et al. Appearance and transient expression of oxytocin receptors in fetal, infant, and peripubertal rat brain studied by autoradiography and electrophysiology. J Neurosci 1989; 9: 1764-1773.
14. Shapiro LE, Insel TR. Ontogeny of oxytocin receptors in rat forebrain: a quantitative study. Synapse 1989; 4: 259-266.
15. Patka JH, Lodolce AE, Johnston AK. High- versus low-dose oxytocin for augmentation or induction of labor. Ann Pharmacother 2005; 39: 95-101.
16. Bruckner TA, Cheng YW, Caughey AB. Increased neonatal mortality among normal-weight births beyond 41 weeks of gestation in California. Am J Obstet Gynecol, 2008; 199: 421 e1-421 e7.
17. Rajan PV, Wing DA. Postpartum hemorrhage: evidence-based medical interventions for prevention and treatment. Clin Obstet Gynecol 2010; 53: 165-181.
18. Laughon SK, et al. Induction of labor in a contemporary obstetric cohort. Am J Obstet Gynecol, 2012; 206: 486 e1-486 e9.
19. Declercq ER, et al. Listening to Mothers II: report of the second national U.S. survey of women's childbearing experiences: conducted January-February 2006 for childbirth connection by Harris Interactive(R) in partnership with Lamaze International. J Perinat Educ 2007; 16: 9-14.
20. Petersen A, et al. The sequence of intrapartum interventions: a descriptive approach to the cascade of interventions. Arch Gynecol Obstet, 2013; 288: 245-254.
21. Moleti CA. Trends and controversies in labor induction. MCN Am J Matern Child Nurs, 2009; 34: 40-47.
22. Martin JA, et al. Births: final data for 2000. Natl Vital Stat Rep 2002; 50: 1-101.
23. Martin JA, et al. Births: final data for 2012. Natl Vital Stat Rep 2013; 62: 1-87.
24. Belghiti J, et al. [Oxytocin administration during labor. Results from the 2010 French National Perinatal Survey]. J Gynecol Obstet Biol Reprod (Paris), 2013; 42: 662-670.
25. Olza Fernandez I, et al. Mode of delivery may influence neonatal responsiveness to maternal separation. Early Hum Dev, 2013; 89: 332-342.
26. Miranda JE, et al. The effect of guideline variations on the implementation of active management of the third stage of labor. Int J Gynaecol Obstet, 2013; 121: 266-269.
27. Obstetrics A.C.o.P.B. ACOG Practice Bulletin No. 107: Induction of labor. Obstet Gynecol, 2009; 1: 386-397.
28. Lydon-Rochelle MT, et al. Induction of labor in the absence of standard medical indications: incidence and correlates. Med Care 2007; 45: 505-512.
29. Out JJ, et al. Characteristics and motives of women choosing elective induction of labour. J Psychosom Res 1986; 30: 375-380.
30. Wei SQ, et al. High-dose vs low-dose oxytocin for labor augmentation: a systematic review. Am J Obstet Gynecol 2010; 203: 296-304.
31. Simmons SW, et al. Combined spinal-epidural versus epidural analgesia in labour. Cochrane Database Syst Rev, 2012; 10: CD003401.
32. Zheng JJ, et al. Oxytocin mediates early experience-dependent cross-modal plasticity in the sensory cortices. Nat Neurosci, 2014; 17: 391-399.
33. Csaba G. The biological basis and clinical significance of hormonal imprinting, an epigenetic process. Clin Epigenetics 2011; 2: 187-196.
34. Csaba G. Phylogeny and ontogeny of hormone receptors: the selection theory of receptor formation and hormonal imprinting. Biol Rev Camb Philos Soc 1980; 55: 47-63.
35. Abrams ET, Rutherford JN. Framing postpartum hemorrhage as a consequence of human placental biology: an evolutionary and comparative perspective. Am Anthropol 2011; 113: 417-430.
36. Glatz TH, et al. Metabolic clearance rate and transplacental passage of oxytocin in the pregnant ewe and fetus. Endocrinology 1980; 106: 1006-1011.
37. Glatz TH, et al. Ovine maternal and fetal plasma oxytocin concentrations before and during parturition. Endocrinology 1981; 108: 1328-1332.
38. Patient C, et al. The effect of labour and maternal oxytocin infusion on fetal plasma oxytocin concentration. Br J Obstet Gynaecol 1999; 106: 1311-1313.
39. Padayachi T, et al. Serial oxytocin levels in amniotic fluid and maternal plasma during normal and induced labour. Br J Obstet Gynaecol 1988; 95: 888-893.
40. Oosterbaan HP, Swaab DF. Amniotic oxytocin and vasopressin in relation to human fetal development and labour. Early Hum Dev 1989; 19: 253-262.
41. Oosterbaan HP, Swaab DF. Circulating neurohypophyseal hormones in anencephalic infants. Am J Obstet Gynecol 1987; 157: 117-119.
42. Oosterbaan HP, Swaab DF, Boer GJ. Oxytocin and vasopressin in the rat do not readily pass from the mother to the amniotic fluid in late pregnancy. J Dev Physiol 1985; 7: 55-62.
43. Malek A, Blann E, Mattison DR. Human placental transport of oxytocin. J Matern Fetal Med 1996; 5: 245-255.
44. Kuwabara Y, et al. Oxytocin levels in maternal and fetal plasma, amniotic fluid, and neonatal plasma and urine. Arch Gynecol Obstet 1987; 241: 13-23.
45. Endoh H, et al. Stimulation of fetal hypothalamus induces uterine contractions in pregnant rats at term. Biol Reprod 2008; 79: 633-637.
46. Alstein M, et al. An immunochemical analysis of oxytocin and vasopressin prohormone processing in vivo. Peptides 1988; 9: 87-105.
47. Chard T, et al. Release of oxytocin and vasopressin by the human foetus during labour. Nature 1971; 234: 352-354.
48. Marchini G, et al. Fetal and maternal plasma levels of gastrin, somatostatin and oxytocin after vaginal delivery and elective cesarean section. Early Hum Dev 1988; 18: 73-79.
49. Szeto A, et al. Evaluation of enzyme immunoassay and radioimmunoassay methods for the measurement of plasma oxytocin. Psychosom Med 2011; 73: 393-400.
50. Martin WL, Carter CS. Oxytocin and Vasopressin are Sequestered in Plasma, in Wold Congress on Neurohypophyseal Hormones. 2013; Bristol, UK.
51. Neumann I, et al. Oxytocin released within the supraoptic nucleus of the rat brain by positive feedback action is involved in parturition-related events. J Neuroendocrinol 1996; 8: 227-233.
52. Neuwelt EA. Mechanisms of disease: the blood-brain barrier. Neurosurgery, 2004; 54: 131-140.
53. Takata F, et al. In vitro blood-brain barrier models using brain capillary endothelial cells isolated from neonatal and adult rats retain age-related barrier properties. PLoS ONE 2013; 8: e55166.
54. Ek CJ, et al. Barriers in the developing brain and neurotoxicology. Neurotoxicology 2012; 33: 586-604.
55. Saunders NR, Habgood MD, Dziegielewska KM. Barrier mechanisms in the brain, II. Immature brain. Clin Exp Pharmacol Physiol 1999; 26: 85-91.
56. Saunders NR, Liddelow SA, Dziegielewska KM. Barrier mechanisms in the developing brain. Front Pharmacol 2012; 3: 46.
57. Anagnostakis D, et al. Blood-brain barrier permeability in 'healthy' infected and stressed neonates. J Pediatr 1992; 121: 291-294.
58. Michalska-Krzanowska G, Drobnik L, Stasiak-Pikula E. Pregnancy induced arterial hypertension - an attempt to evaluate hermetic aspects of the blood-brain barrier connected with skull computed tomography. Przegl Lek 2002; 59: 815-819.
59. Noseworthy MD, Bray TM. Effect of oxidative stress on brain damage detected by MRI and in vivo 31P-NMR. Free Radic Biol Med 1998; 24: 942-951.
60. Loup F, et al. Localization of oxytocin binding sites in the human brainstem and upper spinal cord: an autoradiographic study. Brain Res 1989; 500: 223-230.
61. Hosono T, et al. Neuronal actions of oxytocin on the subfornical organ of male rats. Am J Physiol 1999; 276: E1004-E1008.
62. Jurzak M, Muller AR, Gerstberger R. Characterization of vasopressin receptors in cultured cells derived from the region of rat brain circumventricular organs. Neuroscience 1995; 65: 1145-1159.
63. Ermisch A, et al. Blood-brain barrier and peptides. J Cereb Blood Flow Metab 1985; 5: 350-357.
64. Ferguson AV, et al. Circumventricular structures: CNS sensors of circulating peptides and autonomic control centres. Endocrinol Exp 1990; 24: 19-27.
65. Ho JM, Blevins JE. Coming full circle: contributions of central and peripheral oxytocin actions to energy balance. Endocrinology 2013; 154: 589-596.
66. McEwen BB. Expansion of vasopressin/oxytocin memory research III: research summary and commentary on theoretical and methodological issues. Adv Pharmacol, 2004; 50: 421-451.
67. McEwen BB. Expansion of vasopressin/oxytocin memory research II: brain structures and transmitter systems involved in the influence of vasopressin and oxytocin on memory processing. Adv Pharmacol, 2004; 50: 389-420.
68. McEwen BB. Expansion of vasopressin/oxytocin memory research I: peripheral administration. Adv Pharmacol, 2004; 50: 339-388.
69. Cushing BS, Carter CS. Peripheral pulses of oxytocin increase partner preferences in female, but not male, prairie voles. Horm Behav 2000; 37: 49-56.
70. Witt DM, Carter CS, Walton DM. Central and peripheral effects of oxytocin administration in prairie voles (Microtus ochrogaster). Pharmacol Biochem Behav 1990; 37: 63-69.
71. Grippo AJ, et al. Oxytocin protects against negative behavioral and autonomic consequences of long-term social isolation. Psychoneuroendocrinology 2009; 34: 1542-1553.
72. Churchland PS, Winkielman P. Modulating social behavior with oxytocin: how does it work? What does it mean? Horm Behav 2012; 61: 392-399.
73. Guastella AJ, MacLeod C. A critical review of the influence of oxytocin nasal spray on social cognition in humans: evidence and future directions. Horm Behav 2012; 61: 410-418.
74. Neumann ID, et al. Increased brain and plasma oxytocin after nasal and peripheral administration in rats and mice. Psychoneuroendocrinology, 2013; 38: 1985-1993.
75. Cushing BS, et al. Central expression of c-Fos in neonatal male and female prairie voles in response to treatment with oxytocin. Brain Res Dev Brain Res 2003; 143: 129-136.
76. Nagasaka T, et al. Immunohistochemical localization of placental leucine aminopeptidase/oxytocinase in normal human placental, fetal and adult tissues. Reprod Fertil Dev 1997; 9: 747-753.
77. Nomura S, et al. Gene regulation and physiological function of placental leucine aminopeptidase/oxytocinase during pregnancy. Biochim Biophys Acta 2005; 1751: 19-25.
78. Matsui M, Fowler JH, Walling LL. Leucine aminopeptidases: diversity in structure and function. Biol Chem 2006; 387: 1535-1544.
79. Ishii M, et al. Oxytocin hypersensitivity in pregnant P-LAP deficient mice. Life Sci 2009; 84: 668-672.
80. Pham V, et al. Reproduction and maternal behavior in insulin-regulated aminopeptidase (IRAP) knockout mice. Peptides 2009; 30: 1861-1865.
81. Wallis MG, Lankford MF, Keller SR. Vasopressin is a physiological substrate for the insulin-regulated aminopeptidase IRAP. Am J Physiol Endocrinol Metab 2007; 293: E1092-E1102.
82. Gard PR, et al. Interactions of angiotensin IV and oxytocin on behaviour in mice. J Renin Angiotensin Aldosterone Syst 2007; 8: 133-138.
83. Baker PN, Broughton Pipkin F, Symonds EM. Longitudinal study of platelet angiotensin II binding in human pregnancy. Clin Sci (Lond), 1992; 82: 377-381.
84. Sykes SD, et al. The balance between human maternal plasma angiotensin II and angiotensin 1-7 levels in early gestation pregnancy is influenced by fetal sex. J Renin Angiotensin Aldosterone Syst, 2013; Feb 25. [Epub ahead of print].
85. Loyens E, et al. Antidepressant-like effects of oxytocin in mice are dependent on the presence of insulin-regulated aminopeptidase. Int J Neuropsychopharmacol, 2013; 16: 1153-1163.
86. Arletti R, Bertolini A. Influence of protease inhibitors on the antidepressant activity of oxytocin. Neuropeptides 1987; 10: 241-248.
87. Arletti R, et al. Aged rats are still responsive to the antidepressant and memory-improving effects of oxytocin. Neuropeptides 1995; 29: 177-182.
88. Arletti R, Bertolini A. Oxytocin acts as an antidepressant in two animal models of depression. Life Sci 1987; 41: 1725-1730.
89. Mazzuca M, et al. Newborn analgesia mediated by oxytocin during delivery. Front Cell Neurosci 2011; 5: 3.
90. Khazipov R, Tyzio R, Ben-Ari Y. Effects of oxytocin on GABA signalling in the foetal brain during delivery. Prog Brain Res 2008; 170: 243-257.
91. Tyzio R, et al. Maternal oxytocin triggers a transient inhibitory switch in GABA signaling in the fetal brain during delivery. Science 2006; 314: 1788-1792.
92. Tyzio R, et al. Oxytocin-mediated GABA inhibition during delivery attenuates autism pathogenesis in rodent offspring. Science 2014; 343: 675-679.
93. Carter CS. Oxytocin pathways and the evolution of human behavior. Annu Rev Psychol, 2014; 65: 17-39.
94. Nair PK, et al. Oxytocin-induced labor augments IL-1beta-stimulated lung fluid absorption in fetal guinea pig lungs. Am J Physiol Lung Cell Mol Physiol 2005; 289: L1029-L1038.
95. Wellmann S, Buhrer C. Who plays the strings in newborn analgesia at birth, vasopressin or oxytocin? Front Neurosci 2012; 6: 78.
96. Schaller F, et al. A single postnatal injection of oxytocin rescues the lethal feeding behaviour in mouse newborns deficient for the imprinted Magel2 gene. Hum Mol Genet 2010; 19: 4895-4905.
97. Higashida H, et al. Oxytocin signal and social behaviour: comparison among adult and infant oxytocin, oxytocin receptor and CD38 gene knockout mice. J Neuroendocrinol 2010; 22: 373-379.
98. Boer GJ, Kruisbrink J. Effects of continuous administration of oxytocin by an accurel device on parturition in the rat and on development and diuresis in the offspring. J Endocrinol 1984; 101: 121-129.
99. Holdstock NB, Allen VL, Fowden AL. Pancreatic endocrine function in newborn pony foals after induced or spontaneous delivery at term. Equine Vet J Suppl 2012; 44(Suppl. 41): 30-37.
100. Carter CS. Developmental consequences of oxytocin. Physiol Behav 2003; 79: 383-397.
101. Yamamoto Y, et al. Neonatal manipulations of oxytocin alter expression of oxytocin and vasopressin immunoreactive cells in the paraventricular nucleus of the hypothalamus in a gender-specific manner. Neuroscience 2004; 125: 947-955.
102. Bales KL, et al. Neonatal oxytocin manipulations have long-lasting, sexually dimorphic effects on vasopressin receptors. Neuroscience 2007; 144: 38-45.
103. Bales KL, et al. Oxytocin has dose-dependent developmental effects on pair-bonding and alloparental care in female prairie voles. Horm Behav 2007; 52: 274-279.
104. Kenkel WM, et al. The epigenetic influence of exogenous oxytocin at birth. Soc Neurosci 2011.
105. Bales KL, et al. Effects of neonatal oxytocin manipulations on male reproductive potential in prairie voles. Physiol Behav 2004; 81: 519-526.
106. Kramer KM, et al. The organizational effects of oxytocin on the central expression of estrogen receptor alpha and oxytocin in adulthood. BMC Neurosci 2007; 8: 71.
107. Pournajafi-Nazarloo H, et al. Neonatal oxytocin treatment modulates oxytocin receptor, atrial natriuretic peptide, nitric oxide synthase and estrogen receptor mRNAs expression in rat heart. Peptides 2007; 28: 1170-1177.
108. Young E, et al. Neonatal manipulation of oxytocin alters oxytocin levels in the pituitary of adult rats. Horm Metab Res 2005; 37: 397-401.
109. Eaton JL, et al. Organizational effects of oxytocin on serotonin innervation. Dev Psychobiol 2012; 54: 92-97.
110. Hashemi F, et al. Effect of a single neonatal oxytocin treatment (hormonal imprinting) on the biogenic amine level of the adult rat brain: could oxytocin-induced labor cause pervasive developmental diseases? Reprod Sci, 2013; 20: 1255-1263.
111. Trevathan WR. Maternal 'en face' orientation during the first hour after birth. Am J Orthopsychiatry 1983; 53: 92-99.
112. Fernandez IO, et al. Newborn feeding behavior depressed by intrapartum oxytocin: a pilot study. Acta Paediatr, 2012; 101: 749-754.
113. Bell AF, White-Traut R, Rankin K. Fetal exposure to synthetic oxytocin and the relationship with prefeeding cues within one hour postbirth. Early Hum Dev, 2013; 89: 137-143.
114. Handlin L, et al. Influence of common birth interventions on maternal blood pressure patterns during breastfeeding 2 days after birth. Breastfeed Med 2012; 7: 93-99.
115. Jonas W, et al. Influence of oxytocin or epidural analgesia on personality profile in breastfeeding women: a comparative study. Arch Womens Ment Health 2008; 11: 335-345.
116. Bell A, Erickson E, Carter CS. Beyond labor: the role of natural and synthetic oxytocin in the transition to motherhood. J Midwifery Womens Health, 2014; 59: 35-42.
117. Neumann ID. Brain mechanisms underlying emotional alterations in the peripartum period in rats. Depress Anxiety 2003; 17: 111-121.
118. Champagne FA, Meaney MJ. Stress during gestation alters postpartum maternal care and the development of the offspring in a rodent model. Biol Psychiatry 2006; 59: 1227-1235.
119. Hillerer KM, et al. Exposure to chronic pregnancy stress reverses peripartum-associated adaptations: implications for postpartum anxiety and mood disorders. Endocrinology 2011; 152: 3930-3940.
120. Autism, Developmental Disabilities Monitoring Network Surveillance Year Principal, Investigators Centers for Disease, Control Prevention, Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. MMWR Surveill Summ, 2012; 61: 1-19.
121. Autism, Developmental Disabilities Monitoring Network Surveillance Year Principal, Investigators Centers for Disease, Control Prevention, Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, United States, 2006. MMWR Surveill Summ, 2009; 58: 1-20.
122. Autism, Developmental Disabilities Monitoring Network Surveillance Year Principal, Investigators Centers for Disease, Control Prevention, Prevalence of autism spectrum disorders - Autism And Developmental Disabilities Monitoring Network, 14 sites, United States, 2002. MMWR Surveill Summ, 2007; 56: 12-28.
123. Auyeung B, Lombardo MV, Baron-Cohen S. Prenatal and postnatal hormone effects on the human brain and cognition. Pflugers Arch, 2013; 465: 557-571.
124. Li X, Zou H, Brown WT. Genes associated with autism spectrum disorder. Brain Res Bull 2012; 88: 543-552.
125. Yamasue H. Function and structure in social brain regions can link oxytocin-receptor genes with autistic social behavior. Brain Dev 2013; 35: 111-118.
126. Carter CS. Sex differences in oxytocin and vasopressin: implications for autism spectrum disorders? Behav Brain Res 2007; 176: 170-186.
127. Winslow JT, Insel TR. The social deficits of the oxytocin knockout mouse. Neuropeptides 2002; 36: 221-229.
128. Guastella AJ, et al. Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders. Biol Psychiatry 2010; 67: 692-694.
129. Andari E, et al. Promoting social behavior with oxytocin in high-functioning autism spectrum disorders. Proc Natl Acad Sci USA 2010; 107: 4389-4394.
130. Green JJ, Hollander E. Autism and oxytocin: new developments in translational approaches to therapeutics. Neurotherapeutics 2010; 7: 250-257.
131. Green L, et al. Oxytocin and autistic disorder: alterations in peptide forms. Biol Psychiatry 2001; 50: 609-613.
132. Modahl C, et al. Plasma oxytocin levels in autistic children. Biol Psychiatry 1998; 43: 270-277.
133. Gregory SG, et al. Genomic and epigenetic evidence for oxytocin receptor deficiency in autism. BMC Med 2009; 7: 62.
134. Miller M, et al. Oxytocin and vasopressin in children and adolescents with autism spectrum disorders: sex differences and associations with symptoms. Autism Res, 2013; 6: 91-102.
135. Hammock E, et al. Examining autism spectrum disorders by biomarkers: example from the oxytocin and serotonin systems. J Am Acad Child Adolesc Psychiatry, 2012; 51: 712-721 e1.
136. Jacob S, et al. Association of the oxytocin receptor gene (OXTR) in Caucasian children and adolescents with autism. Neurosci Lett 2007; 417: 6-9.
137. Wermter AK, et al. Evidence for the involvement of genetic variation in the oxytocin receptor gene (OXTR) in the etiology of autistic disorders on high-functioning level. Am J Med Genet B Neuropsychiatr Genet 2010; 153B: 629-639.
138. Campbell DB, et al. Association of oxytocin receptor (OXTR) gene variants with multiple phenotype domains of autism spectrum disorder. J Neurodev Disord 2011; 3: 101-112.
139. Devlin B, Melhem N, Roeder K. Do common variants play a role in risk for autism? Evidence and theoretical musings Brain Res 2011; 1380: 78-84.
140. Betancur C, Leboyer M, Gillberg C. Increased rate of twins among affected sibling pairs with autism. Am J Hum Genet 2002; 70: 1381-1383.
141. Lyall K, et al. Pregnancy complications and obstetric suboptimality in association with autism spectrum disorders in children of the Nurses' Health Study II. Autism Res 2012; 5: 21-30.
142. Rosenberg RE, et al. Characteristics and concordance of autism spectrum disorders among 277 twin pairs. Arch Pediatr Adolesc Med 2009; 163: 907-914.
143. Greenberg DA, et al. Excess of twins among affected sibling pairs with autism: implications for the etiology of autism. Am J Hum Genet 2001; 69: 1062-1067.
144. Chamak B. Autism: overestimation of the genetic origins. Med Sci (Paris) 2010; 26: 659-662.
145. Bohm HV, Stewart MG. Brief report: on the concordance percentages for autistic spectrum disorder of twins. J Autism Dev Disord 2009; 39: 806-808.
146. Gardener H, Spiegelman D, Buka SL. Prenatal risk factors for autism: comprehensive meta-analysis. Br J Psychiatry 2009; 195: 7-14.
147. Gardener H, Spiegelman D, Buka SL. Perinatal and neonatal risk factors for autism: a comprehensive meta-analysis. Pediatrics 2011; 128: 344-355.
148. Stein D, et al. Obstetric complications in individuals diagnosed with autism and in healthy controls. Compr Psychiatry 2006; 47: 69-75.
149. Davis EF, et al. Pre-eclampsia and offspring cardiovascular health: mechanistic insights from experimental studies. Clin Sci (Lond) 2012; 123: 53-72.
150. Uzan J, et al. Pre-eclampsia: pathophysiology, diagnosis, and management. Vasc Health Risk Manag 2011; 7: 467-474.
151. Landau R, et al. Alteration of circulating Placental Leucine Aminopeptidase (P-LAP) activity in preeclampsia. Neuro Endocrinol Lett 2010; 31: 63-66.
152. Akiyama H, et al. Estimation of placental leucine aminopeptidase (P-LAP) in pregnancy sera. Nihon Sanka Fujinka Gakkai Zasshi 1984; 36: 2605-2612.
153. Mizutani S, et al. Plasma angiotensin I and serum placental leucine aminopeptidase (P-LAP) in pre-eclampsia. Arch Gynecol 1985; 236: 165-172.
154. Mizutani S, Tomoda Y. Plasma angiotensin I concentration and serum placental leucine aminopeptidase (P-LAP) activities in puerperal hypertension. Res Commun Chem Pathol Pharmacol 1993; 81: 271-291.
155. Gu H, Rong L, Sha JY. [Changes in blood oxytocin levels in cases of pregnancy induced hypertension]. Zhonghua Fu Chan Ke Za Zhi, 1994; 29: 268-270, 316.
156. Amburgey OA, et al. Plasma from preeclamptic women increases blood-brain barrier permeability: role of vascular endothelial growth factor signaling. Hypertension 2010; 56: 1003-1008.
157. Gofton EN, et al. Obstetrical intervention rates and maternal and neonatal outcomes of women with gestational hypertension. Am J Obstet Gynecol 2001; 185: 798-803.
158. Guinchat V, et al. Pre-, peri- and neonatal risk factors for autism. Acta Obstet Gynecol Scand 2012; 91: 287-300.
159. Mann JR, et al. Pre-eclampsia, birth weight, and autism spectrum disorders. J Autism Dev Disord 2010; 40: 548-554.
160. Wallace AE, Anderson GM, Dubrow R. Obstetric and parental psychiatric variables as potential predictors of autism severity. J Autism Dev Disord 2008; 38: 1542-1554.
161. Burstyn I, Sithole F, Zwaigenbaum L. Autism spectrum disorders, maternal characteristics and obstetric complications among singletons born in Alberta, Canada. Chronic Dis Can 2010; 30: 125-134.
162. Hollander E, et al. A dimensional approach to the autism spectrum. CNS Spectr 1998; 3: 22-39.
163. Wahl RU. Could oxytocin administration during labor contribute to autism and related behavioral disorders?-A look at the literature. Med Hypotheses 2004; 63: 456-460.
164. Dodds L, et al. The role of prenatal, obstetric and neonatal factors in the development of autism. J Autism Dev Disord 2011; 41: 891-902.
165. Glasson EJ, et al. Perinatal factors and the development of autism: a population study. Arch Gen Psychiatry 2004; 61: 618-627.
166. Juul-Dam N, Townsend J, Courchesne E. Prenatal, perinatal, and neonatal factors in autism, pervasive developmental disorder-not otherwise specified, and the general population. Pediatrics 2001; 107: E63.
167. Brimacombe M, Ming X, Lamendola M. Prenatal and birth complications in autism. Matern Child Health J 2007; 11: 73-79.
168. Maramara LA, He W, Ming X. Pre- and perinatal risk factors for autism spectrum disorder in a New Jersey cohort. J Child Neurol, 2014; Jan 10. [Epub ahead of print].
169. Gregory SG, et al. Association of autism with induced or augmented childbirth in North Carolina birth record (1990-1998) and education research (1997-2007) databases. JAMA Pediatr, 2013; 167: 959-966.
170. Mamidala MP, et al. Prenatal, perinatal and neonatal risk factors of autism spectrum disorder: a comprehensive epidemiological assessment from India. Res Dev Disabil 2013; 34: 3004-3013.
171. Polo-Kantola P, et al. Obstetric risk factors and autism spectrum disorders in Finland. J Pediatr 2014; 164: 358-365.
172. Walker CK, et al. Trophoblast inclusions are significantly increased in the placentas of children in families at risk for autism. Biol Psychiatry, 2013; 74: 204-211.
173. Harris JC, Carter CS. Therapeutic interventions with oxytocin: current status and concerns. J Am Acad Child Adolesc Psychiatry 2013; 52: 998-1000.
174. Maccari S, et al. The consequences of early life adversity: neurobiological, behavioural and epigenetic adaptations. J Neuroendocrinol 2014; 26: 707-723.